Blunting p38 MAPKα and ERK1/2 activities by empagliflozin enhances the antifibrotic effect of metformin and augments its AMPK-induced NF-κB inactivation in mice intoxicated with carbon tetrachloride
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blunting p38 MAPKα and ERK1/2 activities by empagliflozin enhances the antifibrotic effect of metformin and augments its AMPK-induced NF-κB inactivation in mice intoxicated with carbon tetrachloride
Authors
Keywords
Metformin/empagliflozin, AMPKα, NF-κB, p38 MAPK, ERK1/2, Liver fibrosis
Journal
LIFE SCIENCES
Volume 286, Issue -, Pages 120070
Publisher
Elsevier BV
Online
2021-10-22
DOI
10.1016/j.lfs.2021.120070
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pretreatment with metformin protects mice from whole-body irradiation
- (2021) Fei Da et al. JOURNAL OF RADIATION RESEARCH
- BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R/NLRP3 and MyD88/NF-κB signaling in DSS-induced colitis in rats
- (2021) Sameh Saber et al. LIFE SCIENCES
- Dapagliflozin, an SGLT2 inhibitor, ameliorates acetic acid-induced colitis in rats by targeting NFκB/AMPK/NLRP3 axis
- (2021) Magdy Abou El-Rous et al. INFLAMMOPHARMACOLOGY
- Metformin alleviates choline diet-induced TMAO elevation in C57BL/6J mice by influencing gut-microbiota composition and functionality
- (2021) Chunyan Su et al. Nutrition & Diabetes
- Albendazole-loaded cubosomes interrupt the ERK1/2-HIF-1α-p300/CREB axis in mice intoxicated with diethylnitrosamine: A new paradigm in drug repurposing for the inhibition of hepatocellular carcinoma progression
- (2021) Sameh Saber et al. BIOMEDICINE & PHARMACOTHERAPY
- Telmisartan alleviates alcohol-induced liver injury by activation of PPAR-γ/ Nrf-2 crosstalk in mice
- (2021) Amir Mohamed Abdelhamid et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Transforming growth factor–β in tissue fibrosis
- (2020) Nikolaos G. Frangogiannis JOURNAL OF EXPERIMENTAL MEDICINE
- From Overnutrition to Liver Injury: AMP-Activated Protein Kinase in Nonalcoholic Fatty Liver Diseases
- (2020) Peng Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Celastrol augments sensitivity of NLRP3 to CP-456773 by modulating HSP-90 and inducing autophagy in dextran sodium sulphate-induced colitis in rats
- (2020) Sameh Saber et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Empagliflozin ameliorates ethanol-induced liver injury by modulating NF-κB/Nrf-2/PPAR-γ interplay in mice
- (2020) Amir Mohamed Abdelhamid et al. LIFE SCIENCES
- The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2/ROS/NLRP3/Caspase-1-dependent IL-1β and IL-18 secretion
- (2020) Sergiy Sukhanov et al. CELLULAR SIGNALLING
- The potential role of sestrin 2 in liver regeneration
- (2020) Raúl P. Oliveira et al. FREE RADICAL BIOLOGY AND MEDICINE
- Dietary intake of genistein suppresses hepatocellular carcinoma through AMPK-mediated apoptosis and anti-inflammation
- (2019) Sang R. Lee et al. BMC CANCER
- SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
- (2019) Chenguang Li et al. Cardiovascular Diabetology
- Telmisartan attenuates N-nitrosodiethylamine-induced hepatocellular carcinoma in mice by modulating the NF-κB-TAK1-ERK1/2 axis in the context of PPARγ agonistic activity
- (2019) Sameh Saber et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Possible involvement of metformin in downregulation of neuroinflammation and associated behavioural changes in mice
- (2019) Jayesh Mudgal et al. INFLAMMOPHARMACOLOGY
- Targeting oxidative stress, proinflammatory cytokines, apoptosis and toll like receptor 4 by empagliflozin to ameliorate bleomycin-induced lung fibrosis
- (2019) Ahmed M. Kabel et al. RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
- Sestrin2: Its Potential Role and Regulatory Mechanism in Host Immune Response in Diseases
- (2019) Li-Xue Wang et al. Frontiers in Immunology
- Vildagliptin/pioglitazone combination improved the overall glycemic control in type I diabetic rats
- (2018) Amir Mohamed Abdelhamid et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis
- (2018) Jessica Lawrence et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Canagliflozin inhibits interleukin-1β-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms
- (2018) Sarah J. Mancini et al. Scientific Reports
- Lisinopril inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis
- (2018) Sameh Saber et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Oxidative stress in chronic lung disease: From mitochondrial dysfunction to dysregulated redox signaling
- (2018) Albert van der Vliet et al. MOLECULAR ASPECTS OF MEDICINE
- Curcumin Activates AMPK Pathway and Regulates Lipid Metabolism in Rats Following Prolonged Clozapine Exposure
- (2017) Zhen Liu et al. Frontiers in Neuroscience
- Initial Combination of Empagliflozin and Metformin in Patients With Type 2 Diabetes
- (2016) Samy Hadjadj et al. DIABETES CARE
- New Developments on the Treatment of Liver Fibrosis
- (2016) Yukinori Koyama et al. DIGESTIVE DISEASES
- Erratum: Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice
- (2016) Linda A. Gallo et al. Scientific Reports
- The carbon tetrachloride model in mice
- (2015) D Scholten et al. LABORATORY ANIMALS
- Activation of AMPK by metformin inhibits TGF-β-induced collagen production in mouse renal fibroblasts
- (2015) Jiamei Lu et al. LIFE SCIENCES
- Activation of AMP-activated protein kinase by metformin protects human coronary artery endothelial cells against diabetic lipoapoptosis
- (2014) Linnéa Eriksson et al. Cardiovascular Diabetology
- Hepatoprotective effects of berberine on liver fibrosis via activation of AMP-activated protein kinase
- (2014) Jing Li et al. LIFE SCIENCES
- Remodelling the extracellular matrix in development and disease
- (2014) Caroline Bonnans et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Extracellular Matrix and Liver Disease
- (2013) Elena Arriazu et al. ANTIOXIDANTS & REDOX SIGNALING
- Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase
- (2012) Chan Sun Park et al. BIOCHEMICAL PHARMACOLOGY
- AMP-activated protein kinase inhibits TGF-β-induced fibrogenic responses of hepatic stellate cells by targeting transcriptional coactivator p300
- (2011) Joong-Yeon Lim et al. JOURNAL OF CELLULAR PHYSIOLOGY
- NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
- (2011) Tom Luedde et al. Nature Reviews Gastroenterology & Hepatology
- Metformin induces apoptosis of lung cancer cells through activating JNK/p38 MAPK pathway and GADD153
- (2011) N. WU et al. NEOPLASMA
- The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity
- (2010) Keith Brew et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Modulation of Hepatic Fibrosis by c-Jun-N-Terminal Kinase Inhibition
- (2009) Johannes Kluwe et al. GASTROENTEROLOGY
- AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
- (2008) Dana M. Gwinn et al. MOLECULAR CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started